SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In

[@EternallyGreat]

Wonderful discussion!!

[@divadfeb1959]

Thank you for a good discussion :)

[@davin8r]

Thanks for this talk! Is there any reason to believe that an SGLT2 inhibitor might inhibit atherosclerosis and/or cardiovascular events in a non-diabetic patient with established CVD?

[@divadfeb1959]

Do you see SGLT2 y GLP1 of benefit in early diagnosis of diabetes?

[@omaybishernandez31]

how about patients with electrophysiolohy problems

[@megajatt123]

Raising insulin seems like a stupid outcome to desire. Sglp inhibitors all the way

[@DuffyF56]

Until you get Euglycemic DKA due to the SGLP2 Inhibitor.